Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G K Raju

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|February 1, 1992
Fermentation monitoringG K Raju, C L Cooney
Clinical Pharmacology and Therapeutics|September 15, 2016
Benefit-Risk Analysis for Decision-Making: An ApproachG K Raju, K Gurumurthi, R Domike
Orphanet Journal of Rare Diseases|November 8, 2024
Expediting treatments in the 21st century: orphan drugs and accelerated approvalsReuben Domike, G K Raju, Jamie Sullivan, et al.
Bulletin of the World Health Organization|January 1, 1992
Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, south IndiaR Rajendran, G K Raju, S M Nair, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
Using a Benefit-Risk Analysis Approach to Capture Regulatory Decision Making: MelanomaG K Raju, Karthik Gurumurthi, Reuben Domike, et al.
Clinical Pharmacology and Therapeutics|September 13, 2016
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung CancerG K Raju, K Gurumurthi, R Domike, et al.
Clinical Pharmacology and Therapeutics|July 30, 2019
Using a Benefit-Risk Analysis Approach to Capture Regulatory Decision Making: Renal Cell CarcinomaG K Raju, Karthik Gurumurthi, Reuben Domike, et al.
The AAPS Journal|May 24, 2014
Understanding pharmaceutical quality by designLawrence X Yu, Gregory Amidon, Mansoor A Khan, et al.
Clinical Pharmacology and Therapeutics|September 14, 2017
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple MyelomaG K Raju, Karthik Gurumurthi, Reuben Domike, et al.
PDA Journal of Pharmaceutical Science and Technology|October 14, 2022
MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing FacilityAndrea L Koenigsberg, Veronica Fowler, Reuben Domike, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|February 1, 1992
Fermentation monitoringG K Raju, C L Cooney
Clinical Pharmacology and Therapeutics|September 15, 2016
Benefit-Risk Analysis for Decision-Making: An ApproachG K Raju, K Gurumurthi, R Domike
Orphanet Journal of Rare Diseases|November 8, 2024
Expediting treatments in the 21st century: orphan drugs and accelerated approvalsReuben Domike, G K Raju, Jamie Sullivan, et al.
Bulletin of the World Health Organization|January 1, 1992
Prevalence of oral submucous fibrosis in the high natural radiation belt of Kerala, south IndiaR Rajendran, G K Raju, S M Nair, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
Using a Benefit-Risk Analysis Approach to Capture Regulatory Decision Making: MelanomaG K Raju, Karthik Gurumurthi, Reuben Domike, et al.
Clinical Pharmacology and Therapeutics|September 13, 2016
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Non-Small Cell Lung CancerG K Raju, K Gurumurthi, R Domike, et al.
Clinical Pharmacology and Therapeutics|July 30, 2019
Using a Benefit-Risk Analysis Approach to Capture Regulatory Decision Making: Renal Cell CarcinomaG K Raju, Karthik Gurumurthi, Reuben Domike, et al.
The AAPS Journal|May 24, 2014
Understanding pharmaceutical quality by designLawrence X Yu, Gregory Amidon, Mansoor A Khan, et al.
Clinical Pharmacology and Therapeutics|September 14, 2017
A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple MyelomaG K Raju, Karthik Gurumurthi, Reuben Domike, et al.
PDA Journal of Pharmaceutical Science and Technology|October 14, 2022
MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing FacilityAndrea L Koenigsberg, Veronica Fowler, Reuben Domike, et al.
Pageof 2